Skip to content

Agile Therapeutics, Inc.

CIK 0001261249

← back to feed
Revenue (TTM)
$23.46M
+80.0% YoY Q2 Aug 2024
Net Income (TTM)
−$15.2M
+43.1% YoY Q2 Aug 2024
EPS Diluted (TTM)
−$3.87
+88.6% YoY Q2 Aug 2024
Gross Margin
66.1%
Q2 Aug 2024
Operating Margin
-62.4%
Q2 Aug 2024
Net Margin
-64.8%
Q2 Aug 2024
Free Cash Flow (TTM)
−$34.13M
Q2 Aug 2024
Cash
$2.85M
Q2 Aug 2024
Total Debt
$17.9M
Q2 Aug 2024
Shares Outstanding
6.9M sh
Q2 Aug 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings